Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucocutaneous leishmaniasis: a clinicopathologic classification

O P Sangueza1, J M Sangueza, M J Stiller

  • 1Ronald O. Perelman Department of Dermatology, New York University Medical School, New York.

Journal of the American Academy of Dermatology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatomyositis panniculitis: a clinicopathological and immunohistochemical study of 18 cases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

[Advances in molecular biology and their application in the diagnosis and treatment of melanoma].

Actas dermo-sifiliograficas·2010
Same author

Definition of the features of acquired elastotic hemangioma reporting the clinical and histopathological characteristics of 14 patients.

Journal of cutaneous pathology·2009
Same author

Anetodermic mycosis fungoides: a new clinicopathological variant of mycosis fungoides.

The British journal of dermatology·2007
Same author

Axillary granular parakeratosis.

International journal of dermatology·2001
Same journal

"Highlights from JAAD International: Noninvasive imaging for basal cell carcinoma".

Journal of the American Academy of Dermatology·2026
Same journal

Effect of Primary Prophylaxis for Pneumocystis Pneumonia in Patients on Rituximab for Immune-Mediated Dermatologic Conditions: A Systematic Review and Meta-Analysis.

Journal of the American Academy of Dermatology·2026
Same journal

Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study.

Journal of the American Academy of Dermatology·2026
Same journal

Real-World Effectiveness and Safety of Ritlecitinib in Adolescents with Severe Alopecia Areata: A 36-Week Single-Center Study.

Journal of the American Academy of Dermatology·2026
Same journal

Liquid Biopsy in Cutaneous Oncology: Current Practice and Future Directions.

Journal of the American Academy of Dermatology·2026
Same journal

Ethically protecting immunosuppressed patients in shared dermatology spaces.

Journal of the American Academy of Dermatology·2026
See all related articles

A new staging system for mucocutaneous leishmaniasis, a parasitic disease, was developed using clinical and immunologic criteria. This system aids in evaluating patient prognosis and guiding treatment decisions for this South American endemic infection.

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Leishmaniasis is a chronic parasitic disease transmitted by sandflies, impacting millions globally.
  • Mucocutaneous leishmaniasis, caused by Leishmania brasiliensis, is prevalent in South America.

Purpose of the Study:

  • To establish a comprehensive staging system for mucocutaneous leishmaniasis.
  • The system integrates clinical, histopathologic, epidemiologic, and immunologic data.

Main Methods:

  • Evaluation of 75 Bolivian patients with mucocutaneous leishmaniasis.
  • Methods included patient history, physical examination, biopsy analysis (cutaneous, mucosal, bone marrow), and immunologic assessment.

Main Results:

Related Experiment Videos

  • Mucocutaneous leishmaniasis progresses through three distinct clinical stages: primary (cutaneous), cicatricial, and secondary (mucocutaneous).
  • The primary stage includes lymphoplasmocytic, tuberculoid, and diffuse cutaneous phases.
  • The secondary stage encompasses edematous, granulomatous proliferative, and granulomatous necrotizing phases.

    • Conclusions:

    • A standardized staging system improves the evaluation of mucocutaneous leishmaniasis patients.
    • Accurate staging enhances prognosis determination and treatment planning for this disease.